• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物化学中的决策:我们直觉的力量。

Decision Making in Medicinal Chemistry: The Power of Our Intuition.

作者信息

Gomez Laurent

机构信息

Gomez Consulting, San Diego, California 92129, United States.

出版信息

ACS Med Chem Lett. 2018 Sep 11;9(10):956-958. doi: 10.1021/acsmedchemlett.8b00359. eCollection 2018 Oct 11.

DOI:10.1021/acsmedchemlett.8b00359
PMID:30344897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6187401/
Abstract

Medicinal chemists rely on their intuition to make decisions regarding the course of a medicinal chemistry program. Our ability to accurately and efficiently process large data sets routinely requires that we reduce the volume of information to manageable proportions. This prioritization process, however, can be affected by intuitive biases. One such situation is structure-activity relationship (SAR) analysis in nonadditive data sets in which attempts to intuitively predict the activity of compounds based on preliminary data can lead to erroneous conclusions. Matrix analysis can be a useful tool to accurately determine the nature of the SAR and to improve our decision-making process during an analoging campaign.

摘要

药物化学家依靠直觉来决定药物化学项目的进程。我们准确且高效地常规处理大型数据集的能力要求我们将信息量减少到可管理的比例。然而,这种优先级排序过程可能会受到直觉偏差的影响。一种这样的情况是非加和数据集中的构效关系(SAR)分析,在这种分析中,基于初步数据直观预测化合物活性的尝试可能会导致错误的结论。矩阵分析可以成为准确确定SAR性质并在类似物研究中改进我们决策过程的有用工具。

相似文献

1
Decision Making in Medicinal Chemistry: The Power of Our Intuition.药物化学中的决策:我们直觉的力量。
ACS Med Chem Lett. 2018 Sep 11;9(10):956-958. doi: 10.1021/acsmedchemlett.8b00359. eCollection 2018 Oct 11.
2
Monitoring the Progression of Structure-Activity Relationship Information during Lead Optimization.在先导化合物优化过程中监测构效关系信息的进展
J Med Chem. 2016 May 12;59(9):4235-44. doi: 10.1021/acs.jmedchem.5b01428. Epub 2015 Nov 16.
3
Inside the mind of a medicinal chemist: the role of human bias in compound prioritization during drug discovery.药物化学家的内心世界:在药物发现过程中化合物优先级排序中人为偏见的作用。
PLoS One. 2012;7(11):e48476. doi: 10.1371/journal.pone.0048476. Epub 2012 Nov 21.
4
Chemical Intuition in Drug Design and Discovery.药物设计与发现中的化学直觉
Curr Top Med Chem. 2019;19(19):1679-1693. doi: 10.2174/1568026619666190620144142.
5
Intuitive Choices Lead to Intensified Positive Emotions: An Overlooked Reason for "Intuition Bias"?直觉选择会引发更强烈的积极情绪:“直觉偏差”一个被忽视的原因?
Front Psychol. 2017 Nov 7;8:1942. doi: 10.3389/fpsyg.2017.01942. eCollection 2017.
6
Systematic computational analysis of structure-activity relationships: concepts, challenges and recent advances.系统计算分析结构-活性关系:概念、挑战与最新进展。
Future Med Chem. 2009 Jun;1(3):451-66. doi: 10.4155/fmc.09.41.
7
Factors that impact on emergency nurses' ethical decision-making ability.影响急诊护士伦理决策能力的因素。
Nurs Ethics. 2018 Nov;25(7):855-866. doi: 10.1177/0969733016674769. Epub 2016 Nov 10.
8
Assessment of the consistency of medicinal chemists in reviewing sets of compounds.评估药物化学家在审查化合物组时的一致性。
J Med Chem. 2004 Sep 23;47(20):4891-6. doi: 10.1021/jm049740z.
9
Using the Benner intuitive-humanistic decision-making model in action: a case study.运用本纳直觉-人本主义决策模型付诸实践:案例研究。
Nurse Educ Pract. 2010 Sep;10(5):303-7. doi: 10.1016/j.nepr.2010.01.009. Epub 2010 Mar 3.
10
Intuition in clinical decision-making: a psychological penumbra.临床决策中的直觉:一种心理边缘地带。
Int J Palliat Nurs. 2008 Oct;14(10):492-6. doi: 10.12968/ijpn.2008.14.10.31493.

引用本文的文献

1
FOCUS on NOD2: Advancing IBD Drug Discovery with a User-Informed Machine Learning Framework.聚焦于NOD2:通过用户反馈的机器学习框架推进炎症性肠病药物研发
ACS Med Chem Lett. 2024 Jun 6;15(7):1057-1070. doi: 10.1021/acsmedchemlett.4c00148. eCollection 2024 Jul 11.
2
Molecule auto-correction to facilitate molecular design.分子自动纠错以促进分子设计。
J Comput Aided Mol Des. 2024 Feb 16;38(1):10. doi: 10.1007/s10822-024-00549-1.
3
Extracting medicinal chemistry intuition via preference machine learning.通过偏好机器学习提取药物化学直觉。
Nat Commun. 2023 Oct 31;14(1):6651. doi: 10.1038/s41467-023-42242-1.
4
To Affinity and Beyond: A Personal Reflection on the Design and Discovery of Drugs.从亲和力到超越:药物设计与发现的个人反思。
Molecules. 2022 Nov 7;27(21):7624. doi: 10.3390/molecules27217624.
5
On drug discovery against infectious diseases and academic medicinal chemistry contributions.关于抗传染病药物研发及学术药物化学的贡献。
Beilstein J Org Chem. 2022 Sep 29;18:1355-1378. doi: 10.3762/bjoc.18.141. eCollection 2022.
6
Improving the odds of success in antitumoral drug development using scoring approaches towards heterocyclic scaffolds.利用杂环支架的评分方法提高抗肿瘤药物开发的成功率。
Oncol Rep. 2020 Aug;44(2):589-598. doi: 10.3892/or.2020.7636. Epub 2020 Jun 5.

本文引用的文献

1
Mathematical and Structural Characterization of Strong Nonadditive Structure-Activity Relationship Caused by Protein Conformational Changes.数学和结构特征分析强非加性构效关系,该关系由蛋白质构象变化引起。
J Med Chem. 2018 Sep 13;61(17):7754-7766. doi: 10.1021/acs.jmedchem.8b00713. Epub 2018 Aug 20.
2
Strong nonadditivity as a key structure-activity relationship feature: distinguishing structural changes from assay artifacts.强非加和性作为关键的构效关系特征:区分结构变化与检测假象。
J Chem Inf Model. 2015 Mar 23;55(3):483-94. doi: 10.1021/acs.jcim.5b00018. Epub 2015 Mar 11.
3
An information theory account of cognitive control.一种认知控制的信息论解释。
Front Hum Neurosci. 2014 Sep 2;8:680. doi: 10.3389/fnhum.2014.00680. eCollection 2014.
4
Inside the mind of a medicinal chemist: the role of human bias in compound prioritization during drug discovery.药物化学家的内心世界:在药物发现过程中化合物优先级排序中人为偏见的作用。
PLoS One. 2012;7(11):e48476. doi: 10.1371/journal.pone.0048476. Epub 2012 Nov 21.
5
Calculation of molecular lipophilicity: State-of-the-art and comparison of log P methods on more than 96,000 compounds.分子亲脂性的计算:最新技术及对96000多种化合物的log P方法比较
J Pharm Sci. 2009 Mar;98(3):861-93. doi: 10.1002/jps.21494.
6
Judgment under Uncertainty: Heuristics and Biases.《不确定性下的判断:启发式与偏差》
Science. 1974 Sep 27;185(4157):1124-31. doi: 10.1126/science.185.4157.1124.
7
Pyrazole CCK(1) receptor antagonists. Part 1: Solution-phase library synthesis and determination of Free-Wilson additivity.吡唑类胆囊收缩素(CCK)(1)受体拮抗剂。第1部分:溶液相库合成及自由威尔逊加和性的测定。
Bioorg Med Chem Lett. 2006 Jan 1;16(1):72-6. doi: 10.1016/j.bmcl.2005.09.048. Epub 2005 Oct 19.
8
Pyrazole CCK(1) receptor antagonists. Part 2: SAR studies by solid-phase library synthesis and determination of Free-Wilson additivity.吡唑类胆囊收缩素(CCK)(1)受体拮抗剂。第2部分:通过固相库合成进行的构效关系研究及自由威尔逊加和性的测定
Bioorg Med Chem Lett. 2006 Jan 1;16(1):77-80. doi: 10.1016/j.bmcl.2005.09.041. Epub 2005 Oct 19.
9
Assessment of the consistency of medicinal chemists in reviewing sets of compounds.评估药物化学家在审查化合物组时的一致性。
J Med Chem. 2004 Sep 23;47(20):4891-6. doi: 10.1021/jm049740z.
10
Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties.基于片段贡献之和的分子极性表面积快速计算及其在药物转运性质预测中的应用。
J Med Chem. 2000 Oct 5;43(20):3714-7. doi: 10.1021/jm000942e.